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transcriptional portrait of M. bovis 
BCG during biofilm production 
shows genes differentially 
expressed during intercellular 
aggregation and substrate 
attachment
Mario Alberto flores‑Valdez1*, Michel de Jesús Aceves‑Sánchez1, eliza J. R. peterson2, 
nitin Baliga2, Jorge Bravo‑Madrigal1, Miguel Ángel De la cruz‑Villegas3, Miguel A. Ares3, 
Sarah Born4, Martin Voskuil4, Nayeli Areli Pérez‑Padilla1, Mirna Burciaga‑flores1, 
Tanya Amanda Camacho‑Villegas1 & María Guadalupe espinoza‑Jorge1
Mycobacterium tuberculosis and M. smegmatis form drug‑tolerant biofilms through dedicated genetic 
programs. In support of a stepwise process regulating biofilm production in mycobacteria, it was 
shown elsewhere that lsr2 participates in intercellular aggregation, while groEL1 was required for 
biofilm maturation in M. smegmatis. Here, by means of RNA‑Seq, we monitored the early steps 
of biofilm production in M. bovis BCG, to distinguish intercellular aggregation from attachment 
to a surface. Genes encoding for the transcriptional regulators dosR and BCG0114 (Rv0081) were 
significantly regulated and responded differently to intercellular aggregation and surface attachment. 
Moreover, a M. tuberculosis H37Rv deletion mutant in the Rv3134c-dosS-dosR regulon, formed less 
biofilm than wild type M. tuberculosis, a phenotype reverted upon reintroduction of this operon 
into the mutant. Combining RT‑qPCR with microbiological assays (colony and surface pellicle 
morphologies, biofilm quantification, Ziehl–Neelsen staining, growth curve and replication of 
planktonic cells), we found that BCG0642c affected biofilm production and replication of planktonic 
BcG, whereas ethR affected only phenotypes linked to planktonic cells despite its downregulation at 
the intercellular aggregation step. our results provide evidence for a stage‑dependent expression of 
genes that contribute to biofilm production in slow‑growing mycobacteria.
In nature, microbial species are often found within a matrix, forming multicellular communities that attach to 
surfaces or air–liquid interfaces, called  biofilms1. Biofilms are relevant to human health, as a majority of bacterial 
pathogens employ these structures to modify the host  response2 contributing to  persistence3. In this regard, a link 
exists between in vitro biofilm production and in vivo persistence for  BCG4 and M. tuberculosis5. Biofilm forma-
tion occurs via a series of well-defined steps. These include the attachment of single-cell planktonic microbes 
onto a substratum; aggregation and growth of the adherent cells into three-dimensionally organized structures; 
and encapsulation of the structures by a self-produced matrix of extracellular polymeric  substance1.
open
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Mycobacterium tuberculosis and M. smegmatis form drug-tolerant biofilms through dedicated genetic 
 programs6,7. In support of a stepwise process regulating biofilm production in mycobacteria, it was recently 
shown that in M. smegmatis, lsr2 participates in intercellular aggregation, while groEL1 was required for biofilm 
 maturation1. Additionally, it was found that multiple genes that are necessary for fitness of M. tuberculosis cells 
within biofilms, were also implicated in tolerance to a diverse set of stressors and  antibiotics8, something not 
observed for planktonic cells, further supporting a role for M. tuberculosis biofilms in drug  tolerance7.
To date, a number of genes have been shown to affect the capacity of mycobacteria to produce biofilms in vitro, 
with few reports describing their specific participation in the stepwise process of regulating biofilm production. 
Here, by means of whole transcriptome analysis, we monitored the early steps of biofilm production in M. bovis 
BCG, to distinguish intercellular aggregation from attachment to a surface. We identified a number of genes 
being differentially expressed at these stages, including genes encoding for the transcriptional regulators linked 
to oxygen availability, dosR and BCG0114 (Rv0081), which were expressed in a temporal order during myco-
bacterial biofilm formation. Our results also provide a potential explanation for a stage-dependent expression 
of additional genes previously reported to contribute to biofilm production in mycobacteria and suggest new 
targets that can be assessed for their particular contribution to this phenotype.
Results
Transcriptional profiling during intercellular aggregation and substrate attachment. Our 
model of biofilm production by BCG consists of four distinct stages based on visual inspection as cultures pro-
gressed in Sauton medium from planktonic cells to mature biofilms. There, BCG starts as free-swimming bac-
teria (24 h) that in the absence of detergent, forms microcolonies of aggregated cells that can be readily visible 
(7 days). Later, these aggregates attach to the plastic wells (10 days), to finally produce mature surface pellicles 
that cover all the air–liquid interphase as well as part of the plastic wells (14 days). We previously demonstrated 
that it is possible to visually detect these steps during BCG biofilm formation at these time  points9. To reduce 
potential variation from experiment to experiment, we always started biofilm cultures with cells adjusted at 
OD600nm 0.03.
To investigate how BCG responds to intercellular aggregation, differential gene expression analysis was used 
to compare the transcriptome of 7-day-old cultures (visible intercellular aggregation) as compared with 24 h 
cultures (basal transcriptome of BCG planktonic cells). Next, we interrogated how BCG specifically responds to 
substrate attachment, by comparing the transcriptome of 10 days-old cultures (visible attachment to the plas-
tic walls) as compared with 7 days cultures (visible intercellular aggregation). The BCG Pasteur 1173P2 genome, 
used as a reference, has 4,109 protein and RNA-encoding genes. In our assays, we were able to detect differential 
gene expression [considered as significant (when both  Log2-fold change ≥ 1 or ≤ − 1 plus p < 0.05) or not] when 
comparing intercellular aggregation versus growth as planktonic cells. We found mostly gene downregulation 
during this transition [1503 upregulated (37.5% of the coding potential), 2,605 downregulated (65%), Supple-
mentary Table 1]. For substrate attachment, as compared with intercellular aggregation, there was less of a biased 
response [1975 (49.3%) upregulated and 2,132 (53.2%) downregulated, Supplementary Table 1].
For illustrative purposes, the 30 most significantly up- or down-regulated genes are shown in Table 2. Among 
the most upregulated genes with a known function, we found BCG3184c (Rv3160c, probable TetR-family tran-
scriptional regulator), sigE, fadE23 (fatty-acid-CoA ligase, involved in sulfolipid production)10, hupB (DNA bind-
ing protein), BCG3929 (Rv3866, espG), ppsC (involved in PDIM synthesis), BCG1191 (Rv1130, prpD, 2-methyl-
citrate dehydratase), and BCG1826 (Rv1794, part of the ESX-5 secretion system)11. Of note, 9 out of the 30 most 
downregulated genes in the transition from planktonic cells to intercellular aggregation were members of the 
DosR regulon (Dormancy Survival Regulon). The DosR-regulon is composed of 48 genes that respond to in vitro 
microaerophilic or hypoxic conditions as well as exposure to nitric oxide or replication within  macrophages12,13. 
Genes BCG0115 (Rv0082), BCG0112 (Rv0079), BCG0114 (Rv0081), BCG0113 (Rv0080), BCG3157c (Rv3134c), 
TB31.7 (Rv2623), hspX (Rv2031c), BCG2049c (Rv2030c), and BCG3154 (Rv3131) were downregulated when BCG 
changed from planktonic cells to the intercellular aggregation step.
Interestingly, 14 out of the 30 most upregulated genes in the transition from intercellular aggregation to sur-
face attachment were also part of the DosR regulon: BCG0112 (Rv0079), BCG2051 (acg), BCG2653c (Rv2626c), 
BCG3157c (Rv3134c), BCG1777 (Rv1738), BCG1772c (Rv1733c), TB31.7 (Rv2623), BCG0115 (Rv0082), BCG0614 
(Rv0569), hspX (Rv2031c), BCG3154 (Rv3131), and BCG2049c (Rv2030c). Genes downregulated when BCG 
changed from intercellular aggregation to surface attachment were mostly encoding for hypothetical, conserved 
hypothetical, or membrane-associated proteins, with the exception of the one encoding for DNA-directed RNA 
polymerase subunit α, rpoA.
The total of differentially expressed genes showing a statistically significant difference  (Log2-fold change ≥ 1 
or ≤ − 1, p < 0.05) with respect to the reference, previous growth stage are shown in Supplementary Table 2 
[upregulated during intercellular aggregation, 248 genes (6.2%)], Supplementary Table 3 [downregulated during 
intercellular aggregation, 764 genes (19.1%)], Supplementary Table 4 [upregulated during substrate attachment, 
474 genes (11.8%)], and Supplementary Table 5 [downregulated during substrate attachment, 683 genes (17%)].
Pang et al. described some genes as relevant for biofilm production in M. tuberculosis, such as PE1, nirB, 
PPE5, mycP1, and pks1, among  others14, although their temporal requirement during biofilm production was 
not elucidated. Later, lsr2 was implicated in intercellular  aggregation1. We found that PE1, nirB, and lsr2 were 
moderately upregulated (FC = 0.6, 0.7, and 0.95  Log2, respectively, Supplementary Table 1) during the transition 
from planktonic to intercellular aggregation, while their expression moderately decreased (FC = − 0.88, − 0.64, 
and − 0.8  Log2, respectively, Supplementary Table 1) during substratum attachment. In both instances, the FC set 
up in our screening to find differentially expressed genes  (Log2 ≥ 1) was not reached, and therefore these 3 genes 
were not considered as DE in our analyses, although we acknowledge that the p-value found for these genes was 
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statistically significant and below the threshold of p ≤ 0.05. As for PE5 and pks1, neither of these genes complied 
with FC and p value criteria set up here to be considered as DE.
GroEL1 was reported to be required for biofilm production in M. smegmatis via its binding to KasA and 
regulation of mycolic acids synthesis and biofilm  maturation6. On the other hand, in BCG GL2, deletion of 
groEL1 produced thinner surface pellicles, devoid of PDIM and with 2-carbon longer mycolic  acids15, therefore 
implicating a more complex role for this chaperone in modulation of the cell surface for biofilm production in 
mycobacteria. In our work, transcription of groEL1 was found to be significantly repressed during the transition 
from planktonic to intercellular aggregation (Supplementary Table 1), while it was significantly induced after 
substratum attachment (Supplementary Table 1). In agreement with our recent  report9, genes involved in mycolic 
acid biosynthesis (kasA, kasB, acpM, fas) were significantly induced after substratum attachment (Supplementary 
Table 1), therefore confirming their upregulation during biofilm formation in BCG.
Taken together, the most significant changes that BCG experiences during the early stages of biofilm produc-
tion were the downregulation of genes of the DosR-regulon during intercellular aggregation, and their upregu-
lation upon substrate attachment. Further, we found a plausible explanation for the temporary requirement of 
genes already reported to be required for biofilm production (PE1, nirB, lsr2, groEL1, kasA, kasB, fas, and acpM) 
in mycobacteria.
We then evaluated the expression of BCG0114, dosR, BCG0642c, ethR, and BCG3766c by RT-qPCR. dosR 
and BCG0114 were specifically downregulated at the intercellular aggregation step while both of them were 
upregulated at the substrate attachment stage (Supplementary Table 1), and as part of the DosR-regulon their 
role in regulating expression of other genes have been  described12,13,16. BCG0642c, which encodes for a conserved 
hypothetical protein with a PhdYeFM antitoxin domain, was significantly upregulated only during intercellular 
aggregation and downregulated (p = 0.06) at the substrate attachment step (Supplementary Table 1). ethR was 
specifically downregulated during surface attachment, while BCG3766c, which encodes for a conserved hypo-
thetical proline rich protein, was also was close to significant downregulation during surface attachment and 
almost reached the criteria to be considered as significantly affected during the intercellular aggregation step 
(FC 0.76, p = 0.022).
We sought to evaluate and validate the expression of these 5 selected genes by RT-qPCR at the same stages 
as we did for RNA-Seq analyses (Fig. 1a). Given that the mean Ct value for each gene of interest with respect to 
the reference gene, rrs, showed a statistically significant difference between the 24 h time point compared to the 
remaining ones (p < 0.0001 compared with 7 days, 10 days, and 14 days, one-way ANOVA followed by Tukey’s 
multiple comparison test), we were able only to compare differential gene expression as measured by RNA-Seq 
to that of the substrate attachment (10 days) versus intercellular aggregation (7 days) step as determined by RT-
qPCR. Transcription of the reference gene, rrs, was found to be non-significantly different for biofilm samples 
(mean Ct values of 9.9, 9.7, and 10.7 at days 7, 10, and 14, respectively, with p values 0.9724 for the 10 vs. 7 days 
comparison, 0.2921 for the 14 vs. 7 days comparison, and 0.282 for the 10 vs. 14 days comparison, determined 
by the Brown–Forsythe and Welch ANOVA test followed by Dunnett’s post-hoc comparison). Similarly, rrs 
transcription was not statistically different for planktonic cultures, with mean Ct values of 8.9 (log phase) and 
9.4 (stationary phase cultures, p = 0.1409 after a two-tailed, unpaired t test with Welch correction).
We found an agreement in expression for 4 out of 5 genes, with a slight variation in the magnitude of the 
change measured: BCG0114 (FC = 6.72 by RNA-seq; FC = 2.66 by RT-qPCR), dosR (FC = 3.62 by RNA-Seq; 
FC = 2.4 by RT-qPCR), ethR (FC = 0.35 by RNA-Seq; FC = 0.39 by RT-qPCR), and BCG3766c (FC = 0.48 by RNA-
Seq; FC = 0.67 by RT-qPCR). Only expression of BCG0642c showed discrepancy between RNA-Seq (2.1 mean 
FC) and RT-qPCR (0.46 mean FC).
Further evaluating gene expression by RT-qPCR we noticed that upregulation of BCG0114 and dosR, or 
downregulation of ethR and BCG0642c, which both started at the substrate attachment step, were maintained 
during biofilm maturation (Fig. 1a). Whereas induction of BCG3766c was only found during substrate attach-
ment with no further change during biofilm maturation (Fig. 1a).
To complete our gene expression analyses, we used RT-qPCR to monitor the expression of BCG0114, dosR, 
BCG0642c, ethR, and BCG3766c in planktonic cultures of BCG at early-log and stationary phase (Fig. 1b). Using 
early-log phase cultures as a reference, we observed that expression of all genes in stationary cultures followed 
the same pattern as they did during intercellular aggregation (BCG0114 and dosR upregulated; BCG0642c, ethR, 
and BCG3766c downregulated). Hence, RT-qPCR validated differential expression for 4 out of 5 genes selected 
from RNA-Seq assays. Moreover, it showed that expression of the 5 selected targets in stationary phase planktonic 
cultures resembled the pattern found during intercellular aggregation.
Phenotypic changes in multicellular BCG aggregates derived from increased expression of 
dosR, BCG0114, BCG0642c, ethR, and BCG3766c. Having confirmed that dosR, BCG0114, BCG0642c, 
ethR, and BCG3766c showed differential expression specifically at either the intercellular aggregation or sub-
strate attachment steps, we next evaluated the effect of increasing their expression by inserting an additional 
single copy of each one of them into BCG Pasteur via pMV361, under the control of the strong promoter hsp6017. 
Expression of other genes from this promoter has already been shown by us to result in downstream changes at 
the  transcriptomic18 and proteomic levels, altered infectivity in vitro19, and improved immunogenicity or vac-
cine efficacy in vivo20. Using this approach, we uncoupled gene transcription from the temporary differential 
expression observed in RNA-Seq and RT-qPCR assays.
Our initial assessment of the phenotypic changes in BCG was focused on those related to multicellular 
aggregates, such as colony morphology, surface pellicle appearance, Ziehl–Neelsen staining of biofilm samples, 
and biofilm formed at 10 (substrate attachment) and 14 days (biofilm maturation) as measured by crystal violet 
staining. Regarding colony morphology (Fig. 2a), we found morphological characteristics of the M. tuberculosis 
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complex, such as: irregular form, waxy dry appearance, wrinkled and rough surface with irregular margins. We 
also found some differences among the strains, as follows: BCG strains harboring additional copies of BCG0114 
(BCG::BCG0114), and dosR (BCG::dosR) showed a grayish color, unlike the other strains that presented a light 
yellowish color. Also, both strains produced smaller and flatter colonies compared with the others. The strain 
with an additional copy of BCG3766c (BCG::BCG3766c) was the one most similar to the wild type strain harbor-
ing the empty vector (BCG::pMV361), the only difference was its smaller size, with both of them showing an 
irregular elevation in the center of the colony. Finally, strains harboring an additional copy of ethR (BCG::ethR) 
or BCG0642c (BCG::BCG0642c) were very similar to each other, the main difference being their size (Fig. 2a).
We also observed changes in mature surface pellicle appearance formed in tissue culture flasks, as both 
BCG::BCG0114 and BCG::dosR produced smooth pellicles as opposed to the rugose ones produced by 
BCG::pMV361, BCG::ethR, BCG::BCG0642c, and BCG::BCG3766c, with slight variations among strains in 
apparent rugosity (Fig. 2b).
When we followed biofilm formation in multiwell plates, we noticed that at the substrate attachment step, 
no noticeable difference was found during biofilm formation (10 days, Fig. 2c), and minor variations in surface 
pellicles were observed when biofilms were mature (14 days, Fig. 2d), although a lower rugosity was consistently 
observed for both BCG::BCG0114 and BCG::dosR cultures (Fig. 2d). No major changes were observed in acid-
fastness or intercellular adherence of the different BCG strains in mature biofilms, with the exception of some 
metachromatic-like granules present in BCG::ethR and BCG::BCG0642c (Fig. 2e).
Biofilm formed by any of the BCG strains at the substrate attachment step showed no quantitative difference 
compared with wild type BCG (Fig. 2f), and only BCG::BCG0642c produced more mature biofilm than wild type 
BCG (p < 0.0001) with BCG::BCG3766c almost reaching significance for a reduced production of this structure 
(p = 0.0521, One-Way ANOVA followed by Dunnett’s multiple comparison test) (Fig. 2g). We also evaluated the 
capacity to produce biofilms by M. tuberculosis strains with different dosR contents and found that a mutant 
lacking this operon (H37Rv dosR KO) was affected in its biofilm formation (p = 0.0426, One-Way ANOVA fol-
lowed by Dunnett’s multiple comparison test) with capacity being restored to wild-type levels upon reinsertion 
of the gene into the chromosome (H37Rv dosR KO::Comp, Fig. 2h).
In summary, compared to wild type BCG, hsp60-driven expression of dosR and BCG0114, led to smaller 
colonies on agar, with changes in color and elevation, and also produced smoother surface pellicles with no 
quantitative effect on biofilm production. Moreover, deletion of dosR in M. tuberculosis H37Rv reduced biofilm 
production (Fig. 2). hsp60-driven expression of BCG0642c enhanced biofilm production with formation of 
metachromatic-like granules in acid-fast bacteria (Fig. 2). hsp60-driven expression of BCG3766c reduced colony 
size and surface pellicle rugosity, although less than dosR or BCG0114, and tended to decrease biofilm produc-
tion (Fig. 2). ethR expression from hsp60 did not produce any detectable difference in the assays performed here 
(Fig. 2).
Phenotypic changes in planktonic BCG cells derived from increased expression of dosR, 
BCG0114, BCG0642c, ethR, and BCG3766c. After evaluating the effect of hsp60-driven expression 
of dosR, BCG0114, BCG0642c, ethR, and BCG3766c in BCG multicellular phenotypes, we next evaluated the 
effect of these genes in planktonic BCG cultures. We did not see any major difference in acid-fastness of early-
log phase bacteria, except for the presence of metachromatic-like granules in BCG::BCG0642c (Fig. 3a) as it 
Figure 1.  RT-qPCR analyses of a set of genes specifically regulated at the intercellular and substrate attachment 
steps during biofilm formation in BCG. Relative expression of genes at different steps during biofilm formation 
(a) and as planktonic cultures at early logarithmic and stationary phases (b). Error bars represent standard 
deviations of the mean from three biological replicates, each with technical duplicates, for six total data per 
gene. Brown–Forsythe and Welch ANOVA followed by Dunnett’s multiple comparison test was used to compare 
samples obtained from biofilms. Multiple t tests followed by Holm–Sidak comparison was used for samples 
obtained from planktonic cultures. Brackets encompass the comparisons for which statistically significant p 
values are shown on top of the bars depicting the means.
5
Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:12578  | https://doi.org/10.1038/s41598-020-69152-2
www.nature.com/scientificreports/
Figure 2.  Phenotypic changes in multicellular BCG aggregates derived from increased expression of dosR, BCG0114, BCG0642c, ethR, 
and BCG3766c. BCG strains harboring each one of the indicated genes, under the control of the strong hsp60 promoter, or the empty 
vector (pMV361), were evaluated for different multicellular phenotypes. Isolated, single colonies obtained after 3 weeks of incubation 
at 37 °C on 7H10 OADC agar plates (a). Surface pellicles formed in Sauton media with no detergent at 37 °C, 5%  CO2, for 2-weeks 
in tissue culture flasks (b), 10 days (c) or 2 weeks in 48-well plates. Ziehl–Neelsen staining of the different BCG strains sampled from 
2 weeks-old surface pellicles (e). Biofilm quantification of the different BCG at 10 days (f) or 2 weeks of culture in Sauton media, in 
48-well plates. Biofilm quantification of M. tuberculosis H37Rv wild type, its isogenic deletion mutant devoid of the Rv3134c-dosS-dosR 
operon (H37Rv dosR KO) and its complemented derivative (H37Rv dosR KO::Comp) in 24-well plates using Sauton medium with no 
detergent. For colonies, a 2 mm scale bar is shown, with the mean diameter and standard deviation indicated (a). For surface pellicles, 
images at 10× are shown (b–d). For Ziehl–Neelsen staining, images at 100× are shown (e). All experiments were performed three 
different times, with duplicates (a), or four to six biological duplicates (b–e), and one representative image is shown in all instances. For 
biofilm quantification, the experiment was repeated independently three times and one representative set of results is shown; error bars 
represent standard deviations of the mean from four to six biological replicates, indicated as individual dots (f–h). One-Way ANOVA 
followed by Dunnett’s multiple comparison test was used to assess significance of changes between each recombinant BCG strain 
and wild type BCG harboring the empty vector (f–g), or among the three M. tuberculosis H37Rv strains (h). Brackets encompass the 
comparisons for which statistically significant p values are shown on top of the bars depicting the means.
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occurred for this strain in biofilm cultures (Fig. 2). An apparent tendency to form tight bundles was also noticed 
for BCG::ethR and BCG::BCG3766c, although this was not quantified.
Regarding the growth curve of planktonic BCG cultures, we monitored apparent growth by reading OD600nm 
every 24 h. There, we found that the most pronounced differences observed as an apparent growth delay as 
observed in OD600nm readings occurred when BCG had hsp60-driven expression of either dosR (significant 
differences in days 2 and 3, and from day 5 to day 12) or BCG0114, which significantly differed at all time points 
except at the start of the culture (Fig. 3b). Differences in OD600nm coincided with changes in doubling time for 
the BCG::dosR strain as compared with BCG::pMV361 at days 5 and 10 (46.94 ± 5.96 h vs. 35.6 ± 4.18, p = 0.0176; 
and 67.79 ± 11.42 h vs. 223.17 ± 22.96 h, p = 0.0086, respectively).
Even though OD600nm for BCG::BCG0114 suggested a marked growth defect as compared with wild type 
BCG harboring the empty vector (BCG::pMV361), doubling time indicated that there was indeed a significant 
difference between these strains, but only at day 6 of culture (BCG::pMV361, 55.17 ± 8 h vs. BCG::BCG0114, 
88.65 ± 6.66 h; p = 0.0131). On the other hand, apparent growth of BCG::ethR significantly differed from wild 
type BCG in days 0 (start of the culture) and day 4 (early log-phase) (Fig. 3b), although their doubling time was 
different only at day 5 of culture (BCG::pMV361, 35.6 ± 4.18 h vs. BCG::ethR, 43.37 ± 5.04 h; p = 0.038).
OD600nm readings of BCG0642c significantly differed in days 0, 2, 4, and from day 10 to day 12 (stationary 
phase) (Fig. 3b); however, doubling time differed at day 1 (BCG::pMV361, 20.72 ± 1.33 h vs. BCG::BCG0642c, 
29.05 ± 2 h; p = 0.0181) and day 3 only (BCG::pMV361, 21 ± 0.76 h vs. BCG::BCG0642c, 14.3 ± 1.97 h; p = 0.0067). 
hsp60-driven expression of BCG3766c resulted in significant differences in OD600nm readings at day 2, and from 
day 6 to day 8 (mid-log phase), with doubling time being significantly different at days 2 and 3 of culture (day 2, 
BCG::pMV361, 20.72 ± 1.33 h vs. BCG::BCG3766c, 26.08 ± 1.29 h; p = 0.0065. Day 3, BCG::pMV361, 21 ± 0.76 h 
vs. BCG::BCG3766c, 18.19 ± 0.75 h; p = 0.0111).
Next, we compared bacterial replication as colony-forming units (CFU) per milliliter at 3 stages: day 0 (start 
of the culture), day 4 (early-log phase), and day 10 (stationary phase). We found that despite the apparent growth 
delay produced in BCG upon hsp60-driven expression of dosR or BCG0114, specifically in the mid-log to sta-
tionary phase transition (Fig. 3b), no significant difference in terms of bacterial numbers was found in any of 
Figure 3.  Phenotypic changes in planktonic BCG cells derived from increased expression of dosR, BCG0114, 
BCG0642c, ethR, and BCG3766c. Ziehl–Neelsen staining of the different BCG strains sampled from mid-
log phase planktonic cultures in 7H9 OADC 0.05% Tween 80 (a). Growth (as OD600nm readings) of each 
recombinant BCG was compared with that of parental BCG harboring the empty vector pMV361 (BCG 
WT::pMV361) (b). Two-Way ANOVA followed by Dunnett’s multiple comparison test was used to compare 
apparent growth, using four biological duplicates; p values for the recombinant strains compared with 
BCG::pMV361 being described in results. Bacterial replication (CFU/mL) (c) was compared by 2-Way ANOVA 
followed by Tukey’s multiple comparison test, using four biological duplicates. Each experiment was repeated 
independently two times, and one representative result is shown. Brackets encompass the comparisons for 
which statistically significant p values are shown on top of the bars depicting the means.
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the three stages evaluated here (Fig. 3c). On the other hand, in agreement with differences found in the growth 
curve at day 4, BCG::ethR had higher CFU/mL than wild type BCG (p < 0.0001 for early-log cultures, Fig. 3c). 
Also in agreement with changes observed in growth curve was the replication of early-log and stationary phase 
cultures of BCG::BCG0642c (p = 0.0022 for early-log, and p = 0.0125 for stationary phases cultures, Fig. 3c). 
No significant change was detected in replication of BCG::BCG3766c compared with BCG::pMV361 (Fig. 3c).
Discussion
Bacteria must accurately regulate growth and stress resilience. The formation of biofilms contributes to stress 
survival, since these dense multicellular aggregates, in which cells are embedded in an extracellular matrix of 
self-produced polymers, represent a self-constructed protective ‘niche’21 that yet remains metabolically active 
even after reaching  maturity22.
In M. tuberculosis complex bacteria, biofilm production in vitro has been shown to harbor drug-tolerant 
 bacteria7 and to be genetically linked to this  phenotype8. Drug-tolerant mycobacteria may comprise a fraction 
of the population, as mature M. tuberculosis biofilms showed sensitivity to antibiotic treatment when assessed 
with microcalorimetry (IMC) and tunable diode laser absorption  spectroscopy22. Drug tolerance has also been 
found to occur in ex vivo  caseum23 and is thought to contribute to persistence after drug treatment in vivo24. In 
fact, the lungs of chronically infected mice harbored a subpopulation of nongrowing but metabolically active 
M. tuberculosis25.
Evidence reported over the last decade associate the capacity of M. tuberculosis-complex bacteria with viru-
lence in ex vivo or in vivo  models26. Pang et al.14 found several genes that were required for biofilm production 
using a “formation/no formation” readout, while Yang et al.1 utilized a genetic approach to propose a temporal 
order for development of mycobacterial biofilms using M. smegmatis as model.
In this work, we performed an unbiased, whole transcriptome analysis, aimed to find genes differentially 
expressed during intercellular aggregation and substrate attachment. This followed the rationale that upon affect-
ing their expression levels, this may result in either major or subtle changes during biofilm formation by BCG. 
This contrasts with both Pang et al.14 strategy based on “formation/no formation” readout in microtiter plates, 
and the one used by Yang et al.1 that relied on a clever yet static approach, as these authors screened only one time 
point to look for M. smegmatis mutants with altered capacity to produce biofilms within a syringe-based model.
It is worth noting that we utilized a panel of 5 DE tools to identify gene expression changes. Selection of 
genes with potential relevance for the intercellular aggregation and substrate attachment steps during biofilm 
production by BCG were based on their up- or down-regulation by a twofold or greater change coupled with 
p < 0.05 after multivariate analysis. Using these criteria, we observed that the most significant changes that BCG 
experiences at the early stages of biofilm production are the downregulation of part of the DosR-regulon dur-
ing intercellular aggregation, and their upregulation upon substrate attachment. Therefore, we selected 2 genes 
from this regulon: dosR itself, and BCG0114 (homologous to Rv0081), and characterized the effects of the strong 
expression of these genes from the hsp60 promoter both during multicellular and planktonic growth.
DosR has been shown to respond to oxygen limitation and to the presence of nitric oxide in vitro12,13. We 
found that only the absence of dosR in M. tuberculosis, as opposed to its increased expression in BCG, result in 
reduced biofilm production. We hypothesize that this may be explained by the fact of slow growing mycobacteria 
requiring DosR to metabolically adapt to low  O2 levels as already  reported27. This result is also in agreement 
with reduced dosR transcription and reduced biofilm production observed in a double mutant devoid of the 
exopolyphosphatases  genes28 and also in a mtrB  mutant29.
Changes in surface pellicle appearance during biofilm production upon dosR or BCG0114 expression from 
hsp60, constitute a subtle phenotype that may go unnoticed when assessing transposon insertion mutant for 
“formation/no formation” readout, as we found no quantitative effect on biofilm production. The relevance of 
this biofilm-specific change for other in vitro or in vivo phenotypes remains to be determined. We contend that 
altering either dosR or BCG0114 expression results in unique, biofilm-specific phenotypes, as during planktonic 
growth, their expression from hsp60 delayed logarithmic growth (Fig. 3b) but with no effect on bacterial replica-
tion at the beginning, early-log, and stationary phases (Fig. 3c). This difference might be explained, at least to 
some extent, by differences in oxygen availability in biofilms as has been  suggested9. In support of this hypothesis, 
it is worth noting that the already complex regulatory network utilized by M. tuberculosis to respond to  hypoxia16 
has just been refined using a comprehensive genome-wide transcription factor binding map and network topol-
ogy analysis. This unraveled M. tuberculosis response during the adaptation to varying oxygen levels (normoxia, 
depletion, early-, mid-, and late hypoxia, and resuscitation) and contributed to further support the role of Rv0081 
(BCG0114), DosR, and Lsr2 in adaptation to oxygen  availability30, regulators that were differentially expressed 
at distinct stages of biofilm production in BCG (Table 1).
BCG0642c, which encodes for a conserved hypothetical protein with a PhdYeFM antitoxin domain, was 
significantly upregulated only during the intercellular aggregation step and tended towards downregulation 
(p = 0.06) at the substrate attachment step (Supplementary Table 1). To date, only the structure and function 
as an antitoxin of VapB4 (Rv0596c, the orthologous of BCG0642c) has been  described31 but with no other role 
identified thus far. However, toxin-antitoxin modules have been shown to play a major role in persister forma-
tion in many model  systems32, therefore it seems reasonable to find at least one of these genes as differentially 
expressed and contributing to biofilm production in BCG (Fig. 2). We acknowledge that a unique, biofilm-specific 
role for BCG0642c cannot be claimed at this point, given that its expression from hsp60 also affected planktonic 
replication, positively during early-log phase, and negatively in stationary phase planktonic BCG cultures (Fig. 3).
ethR was specifically downregulated during surface attachment (Supplementary Table 1) but its expression 
from hsp60 resulted in no change during biofilm production (Fig. 2) yet it favored growth and replication dur-
ing early-log phase (Fig. 3). In this regard, a M. bovis BCG ethA-ethR KO mutant showed increased adherence 
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to mammalian  cells33 but its capacity to produce biofilm was not evaluated in that work. Nevertheless, another 
report stated that ethR did not participate in biofilm production in M. tuberculosis34, which seems in agreement 
with our findings in BCG.
The last gene we evaluated was BCG3766c, which encodes for a conserved hypothetical proline rich protein 
(Supplementary Table 1). This gene was significantly downregulated during surface attachment and was also 
downregulated during the intercellular aggregation step as well (FC 0.76, p = 0.022). This may explain why its 
expression from hsp60 tended to reduce biofilm production (Fig. 2).
We also found differential expression for a number of other genes that we did not further evaluate in this 
work, including among the most significantly upregulated genes sigE, fadE23 (fatty-acid-CoA ligase, involved 
in sulfolipid production)10, hupB (DNA binding protein), BCG3929 (Rv3866, espG), ppsC (involved in PDIM 
synthesis), BCG1191 (Rv1130, prpD, 2-methylcitrate dehydratase), and BCG1826 (Rv1794, part of the ESX-5 
secretion system)11. For BCG3929 (Rv3866, espG), a deletion of espG in M. marinum reduced sliding motility and 
Table 1.  Primers, plasmids and bacterial species used in this work Underlined sequences indicate sites for 
endonuclease restriction
Sequence (5′–3′) Primer name Restriction site
Primers used to amplify and clone ORFs under hsp60
GGA GAA TTC ATG GAG TCC GAA CCG CTG BCG_0114-5F EcoRI
CCC AAG CTT TTA CGT GGC CGA GCC BCG_0114-3R HindIII
GTG CAG CTG TCA TGG TAA AGG TCT TCT TGG TCG devR-F-Pvu PvuII
ACT AAG CTT CCT GTT GTC ATG GTC CAT CACCG devR-RHd3 HindIII
ACT GAA TTC ATG TCT GCT ACG ATACC BCG_0642c-5F EcoRI
GCC AAG CTT TCA CCA CCG BCG_0642c-3R HindIII
CAA GAA TTC ATG CGA CAC ATG AGT BCG_3766c-5F EcoRI
GGT AAG CTT TTA CGG AGC GGG BCG_3766c-3R HindIII
GCT GAA TTC ATG ACC ACC TCC EthR-5F EcoRI
GAG AAG CTT TTA GCG GTT CTC G EthR-3R HindIII
Sequence (5′–3′) Primer name
Primers used for real time qPCR
AGT CCG AAC CGC TGT ACA AG BCG0114-5RT
CAG CAG CTC CAA AAT CCT GATC BCG0114-3RT
ATG GCA ACG GCA TTG AAC T dosR-F
AGA ATC GCA TCT AGC ATG GC dosR-R
GTA ATC GCA GAT CAG CAA CG rrs-F
TTC GGG TGT TAC CGA CTT TC rrs-R
ATC TGA AAC CCC AAC ACC AC BCG_3766c-5RT
ATA GCC GGT GAA GAA GAT GACC BCG_3766c-3RT
TGG TCA ATC AAG CCG ACA TG ethR-5RT
TCT CGA AGA ACA CGT TGA TCCC ethR-3RT
ATC GCG CGA AAA ACC ATC TG sigA-F
TGG TGT AGT CGA ACT TCT CCAC sigA-R
AGG AAA TCG AGG TGC TCA AGG BCG_0642c-5RT
TCG CCC AGA TTG GTG GTA TC BCG_0642c-3RT
Plasmid Description
pMV361 Shuttle vector, kanamycin resistance marker, incorporates as single copy into Mycobacterium attB site, can drive gene transcription from the strong hsp60 promoter
pMV361-dosR pMV361 with dosR inserted into PvuII/HindIII sites
pMV361-BCG0114 pMV361 with BCG0114 inserted into EcoRI/HindIII sites
pMV361-BCG0642c pMV361 with BCG0642c inserted into EcoRI/HindIII sites
pMV361-BCG3766c pMV361 with BCG3766c inserted into EcoRI/HindIII sites
pMV361-ethR pMV361 with ethR inserted into EcoRI/HindIII sites
Strain Genotype
M. bovis BCG Pasteur Mycobacterium bovis Karlson and Lessel (ATCC® 35734™) (hereafter referred as to BCG wild type -WT-)
BCG WT::pMV361 BCG Pasteur with an insertion at attB of pMV361 (empty vector)
BCG::dosR BCG Pasteur with an insertion at attB of pMV361-dosR
BCG::BCG0114 BCG Pasteur with an insertion at attB of pMV361-BCG0114
BCG::BCG0642c BCG Pasteur with an insertion at attB of pMV361-BCG0642c
BCG::BCG3766c BCG Pasteur with an insertion at attB of pMV361-BCG3766c
BCG::ethR BCG Pasteur with an insertion at attB of pMV361-ethR
E. coli DH5α F− φ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 hsdR17(rK−, mK+) phoA supE44 λ− thi-1 gyrA96 relA1
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biofilm  formation35. BCG3929 upregulation during intercellular aggregation as compared to planktonic growth 
(Table 2) may explain the defect of the M. marinum mutant in biofilm formation.
Biofilm formation by BCG in the presence of the histone methyltransferase SUV39H1 was reduced, an effect 
proposed to occur via trimethylation of  HupB36. This suggests a positive effect for this DNA-binding protein for 
biofilm production, and it is in agreement with hupB upregulation during intercellular aggregation (Table 2).
Rv3385c (orthologous to BCG3454c) was shown to be repressed in mature biofilms formed upon exposure to 
DTT as compared to late-log cultures of M. tuberculosis37. Redox conditions intervene in modulating M. tuber-
culosis pathogenesis, including activity of  DosR38, which, to add further complexity to the mechanisms of gene 
regulation driven by this transcriptional regulator, was recently shown to be positively affected by c-di-GMP 
binding in M. smegmatis in response, precisely, to oxidative  stress39.
Biofilm-specific proteins were recognized by antibodies present in sera from M. tuberculosis infected guinea 
 pigs40. Of the antigenic proteins reported in that study, we found ceoB and BCG2013 (Rv1996) significantly 
repressed during the transition from planktonic to intercellular aggregation (Supplementary Table 3), while they 
were significantly induced after substratum attachment (Supplementary Table 4). Moreover, BCG2232 (Rv2216) 
and TB39.8 (BCG0050c, Rv0020c, FhaA) were affected specifically after substratum attachment (FC = 1, and 
− 0.74  Log2, respectively, Supplementary Tables 4 and 5). The fact that some biofilm-specific proteins that were 
recognized in vivo had their encoding genes differentially expressed during biofilm production in vitro by BCG 
further strengthen the notion of biofilms mimicking aspects found during TB  pathogenesis26. Taken together, our 
results show that dosR and BCG0114 were expressed in a temporal order during mycobacterial biofilm formation 
to produce biofilm-specific changes, which most likely are triggered in response to varying oxygen levels within 
biofilms. Furthermore, we also provide a potential explanation for a stage dependent expression of additional 
genes previously reported to contribute to biofilm production in mycobacteria and suggest new targets that can 
be assessed for their particular contribution to this phenotype.
Methods
Bacterial strains, growth conditions and RnA extraction. M. bovis BCG Pasteur strain (ATCC 
35734) or M. tuberculosis H37Rv and derivatives with deletion of the Rv3134c-dosR-dosS operon (referred to as 
H37Rv dosR KO in Fig. 2) and its complemented strain (referred to as H37Rv dosR::KO::Comp in Fig. 2)27 were 
used in this study. Planktonic cultures were performed in Middlebrook 7H9 liquid media (BD) with 10% OADC, 
0.2% glycerol, 25 µg/mL of kanamycin, at 37 °C, 100 rpm. Serial dilutions of samples were followed by plating 
onto Middlebrook 7H10 agar plates supplemented with 10% OADC, 0.5% glycerol, and 25 µg/mL kanamycin 
served to determine colony-forming units per milliliter (CFU/mL). Biofilms (which include bacteria attached 
to the plastic wells and surface pellicles) for RNA extraction of BCG strains were cultured in Sauton media as 
already  reported9. After 1, 7, 10 and 14 days of incubation, two culture flasks were used to harvest, with a scraper, 
the whole surface pellicle and biofilm attached to the wells (these samples are referred to as “biofilms”), and 
transferred into 50 mL tubes that were immediately frozen at − 70 °C. From frozen samples, we proceeded to 
perform RNA extraction and purification as already  reported41, to ship these samples to Arizona State University 
for RNA-Seq analyses. The experiment was repeated three (7, 10, and 14 days cultures) or four times (24 h cul-
tures, because of the low biomass present at this time point), to produce independent replicates.
Temporal expression profiling during biofilm production by BCG. RNA was used to prepare cDNA 
using Nugen’s Ovation RNA-Seq System via single primer isothermal amplification (Catalogue # 7102-A01) and 
automated on the (BRAVO NGS liquid handler from Agilent). cDNA was quantified on the Nanodrop (Thermo 
Fisher Scientific). Using Kapa Biosystem’s DNA Hyper Plus library preparation kit, (KK8514) cDNA was enzy-
matically sheared to approximately 150 bp fragments, end repaired and A-tailed. Adapters with unique indexes 
compatible with Illumina (IDT #00989130v2) were ligated on each sample individually, then, these were cleaned 
using Kapa pure beads (Kapa Biosciences, KK8002), followed by amplification with Kapa’s HIFI enzyme (KK2502). 
Using Agilent’s Tapestation, we analyzed fragment size of each library, and quantified them by qPCR (KAPA 
Library Quantification Kit, KK4835) on a Quantstudio 5 (Thermo Fisher Scientific). Next, we multiplex pooled 
and sequenced a 2 × 75 flow cell on the NextSeq500 platform (Illumina) at the ASU’s Genomics Core facility.
RNA‑seq analysis. Raw FASTQ read data were processed using the R package DuffyNGS as described 
 previously42. Briefly, raw reads were passed through a 3-stage alignment pipeline: (1) a prealignment step, to 
remove unwanted transcripts, such as rRNA; (2) a main genomic alignment step against the genome of interest; 
and (3) a splice junction alignment step, compared with an index of standard and alternative exon splice junc-
tions. Reads were aligned to M. bovis BCG str. Pasteur (1173P2) with  Bowtie243, using the command line option 
“very-sensitive.” BAM files from stages (2) and (3) were combined into read depth wiggle tracks that recorded 
both multiply mapped and uniquely mapped reads to each of the forward and reverse strands of the genome of 
reference at single-nucleotide resolution. Next, gene transcript abundance was measured by summing total reads 
found inside annotated gene boundaries, expressed as both RPKM and raw read counts. RNA-seq data (raw fastq 
files and read counts) have been deposited in the GEO repository under accession number GSE150030.
Differentially expressed genes. A panel of 5 DE tools was used to identify gene expression changes 
between 1-week old biofilm samples and 24-h samples (to determine genes affected or necessary for intercel-
lular aggregation or cell-to-cell attachment) or 10-day old biofilm samples and 1-week old biofilm samples (to 
determine genes affected or necessary for substratum attachment to start building up the mature biofilm). The 
tools included (1) RoundRobin (in-house); (2)  RankProduct44; (3) significance analysis of microarrays (SAM)45 
; (4)  EdgeR46; and (5)  DESeq247. Appropriate default parameters were used to call each DE tool and operated 
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Gene_Name Gene_ID Log2fold Avg_p value Product
lppB BCG_2567 2.7988 2.68E−08 Probable conserved lipoprotein lppB
BCG_3184c BCG_3184c 2.5898 1.30E−15
Possible transcriptional regulatory protein (probably tetR-family), orthologous to Rv3160c. Rv3160c was 
involved in response to thioridazine (PLoS One. 2010 Apr 8;5(4):e10069. https ://doi.org/10.1371/journ 
al.pone.00100 69)
PE22 BCG_2124 2.5607 5.75E−15 PE family protein
BCG_2486c BCG_2486c 2.496 0.000174564 Conserved hypothetical protein. Contains a Protein Disulfide Oxidoreductase domain (7.33e−35)
BCG_3185c BCG_3185c 2.4789 5.66E−19 Possible dioxygenase
BCG_1115 BCG_1115 2.4553 3.66E−16 Conserved hypothetical protein. Contains a DNA-binding beta-propeller fold protein YncE. (1.79e−34)
BCG_2748c BCG_2748c 2.3981 3.53E−09 Conserved hypothetical protein. Contains a S-adenosylmethionine-dependent methyltransferases (SAM or AdoMet-MTase), class I domain (8.96e−66)
sigE BCG_1281 2.2979 1.16E−16 Alternative RNA polymerase sigma factor sigE
BCG_0010c BCG_0010c 2.2359 5.18E−21 Probable conserved membrane protein. It contains a 40 aa stretch (out of 111 aa) similar to bacterial plekstrin homology domain (2.65e−8)
BCG_0040c BCG_0040c 2.2296 8.44E−20 Probable conserved membrane protein. It contains a 40 aa stretch (out of 111 aa) similar to bacterial plekstrin homology domain (2.65e−8)
lprR BCG_2566 2.2247 1.51E−09 Probable conserved lipoprotein lprR
fadD23 BCG_3889 2.1317 3.07E−22 Probable fatty-acid-CoA ligase fadD23, involved in sulfolipid production (Microbiology. 2007 Sep;153(Pt 9):3133-40.)
PPE70 BCG_3183c 2.1152 2.70E−20 PPE family protein
hupB BCG_3007c 2.1028 5.22E−07 Probable DNA-binding protein HU homolog hupB
BCG_0088 BCG_0088 2.1007 9.08E−15 Hypothetical protein
BCG_0221 BCG_0221 2.0983 1.45E−11 Conserved hypothetical protein
BCG_3929 BCG_3929 2.0163 8.42E−20
Conserved hypothetical protein. Orthologous Rv3866 (EspG). A deletion of espG in M. marinum reduced 
sliding motility and biofilm formation by M. marinum (Front Microbiol. 2018 May 30;9:1160. https ://doi.
org/10.3389/fmicb .2018.01160 ).
ppsC BCG_2955 1.8996 9.31E−19 Phenolpthiocerol synthesis type-I polyketide synthase ppsC
rplK BCG_0689 1.8485 4.98E−10 Probable 50S ribosomal protein l11 rplK
PPE53 BCG_3182c 1.848 9.55E−17 PPE family protein
recX BCG_2749c 1.7905 5.94E−11 Regulatory protein recX
BCG_0653 BCG_0653 1.7809 3.40E−05 Hypothetical protein
BCG_1191 BCG_1191 1.7798 5.19E−05 Conserved hypothetical protein. Orthologous to Rv1130, PrpD, 2-methylcitrate dehydratase.
BCG_2192c BCG_2192c 1.7692 7.07E−14 Possible transposase
lpqK BCG_0436c 1.7462 6.92E−12 Possible conserved lipoprotein lpqK
BCG_1053 BCG_1053 1.7207 5.49E−09 Hypothetical protein
parA_1 BCG_3976c 1.7153 6.49E−14 Probable chromosome partitioning protein parA
BCG_0343 BCG_0343 1.7095 6.09E−11 Probable dehydrogenase/reductase
BCG_1826 BCG_1826 1.7054 1.42E−09 Conserved hypothetical protein. Orthologous to Rv1794, which is part of the ESX-5 secretion system (Mol Microbiol. 2012 Mar;83(6):1195-209. https ://doi.org/10.1111/j.1365-2958.2012.08001 .x.)
rpsK BCG_3524c 1.704 1.04E−09 Probable 30S ribosomal protein S11 rpsK
tyrT tyrT -4.7515 0.00058183 tRNA-Tyr
BCG_0115 BCG_0115 -4.6431 2.78E−17 Probable oxidoreductase. Orthologous to Rv0082.
BCG_0112 BCG_0112 -4.1372 6.19E−31 Hypothetical protein. Orthologous to Rv0079, part of the DosR-regulon. Contains a 46 aa region (out of 273 aa) with Sigma 54 modulation/S30EA ribosomal protein C-terminus (2.2e−11)
BCG_1838c BCG_1838c -3.8293 2.20E−18 Hypothetical protein
BCG_3001 BCG_3001 -3.7853 9.73E−06 Possible conserved secreted protein
BCG_0114 BCG_0114 -3.5825 4.44E−09 Probable transcriptional regulatory protein. Orthologous to Rv0081. Part of the DosR-regulon.
hycD BCG_0117 -3.3564 1.98E−11 Possible formate hydrogenlyase hycD (FHL)
BCG_0113 BCG_0113 -3.3198 1.60E−08 Conserved hypothetical protein. Orthologous to Rv0080. Part of the DosR-regulon. Contains a Pyridoxine 5’-phosphate (PNP) oxidase-like and flavin reductase-like proteins domain (1.66e−19)
gluU gluU -3.2724 0.000581961 tRNA-Glu
BCG_0410c BCG_0410c -3.1733 0.005478442 Conserved hypothetical protein. Xanthine dehydrogenase accessory factor. Xanthine and CO dehydrogenase maturation factor (3.83e−57)
EBG00001157338 EBG00001157338 -3.1712 0.000181053 tRNA
BCG_3454c BCG_3454c -3.165 1.60E−05 Conserved hypothetical protein. Type II toxin-antitoxin (TA) system Phd/YefM family antitoxin similar to Mycobacterium tuberculosis VapB antitoxins Orthologous to Rv3385c.
BCG_1725c BCG_1725c -3.1551 1.92E−11 Probable conserved ATP-binding protein ABC transporter
BCG_2178c BCG_2178c -3.1213 0.00184171 Conserved hypothetical protein. Contains Flavin-utilizing monoxygenases (4.46e−58)
BCG_2265 BCG_2265 -3.1205 3.06E−08 Conserved hypothetical protein
BCG_3157c BCG_3157c -3.1202 1.23E−14 Conserved hypothetical protein. Orthologous to Rv3134c, in operon with dosR, part of the DosR-regulon. Universal stress protein family.
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Gene_Name Gene_ID Log2fold Avg_p value Product
EBG00001157336 EBG00001157336 -3.081 0.000153611 tRNA
lysU lysU -3.0572 0.000223606 tRNA-Lys
serV serV -2.9977 0.000401639 tRNA-Ser
TB31.7 BCG_2650 -2.9848 6.22E−10 Conserved hypothetical protein TB31.7. Orthologous to Rv2623, part of DosR-regulon. Universal stress protein family.
EBG00001157351 EBG00001157351 -2.9789 5.40E−06 tRNA
iniB BCG_0380 -2.9678 1.85E−17 Isoniazid inductible gene protein iniB
BCG_1777 BCG_1777 -2.9632 2.44E−17 Conserved hypothetical protein
argH BCG_1698 -2.9341 8.39E−07 Probable Argininosuccinate lyase argH
BCG_2266 BCG_2266 -2.9043 7.57E−07 Conserved hypothetical protein. Contains a C-terminal 71 aa stretch similar to Superfamily of nucleases (8.51e−3)
hspX BCG_2050c -2.8879 9.61E−07 Heat shock protein hspX. Orthologous to Rv2031c, alpha crystalin, part of the DosR-regulon.
BCG_2049c BCG_2049c -2.8578 1.28E−07
Conserved hypothetical protein. Orthologous to Rv2030c, part of the DosR-regulon. Contains N-terminal (aa 
15-228) Phosphoribosyl transferase (PRT)-type I domain (4.14e−98) and another stretch (aa 223-663 out of 
681) with Erythromycin esterase homolog domain (8e−155)
BCG_3154 BCG_3154 -2.8493 4.09E−09 Conserved hypothetical protein. Orthologous to Rv3131, part of the DosR-regulon.
BCG_3287c BCG_3287c -2.8072 3.32E−07 Conserved hypothetical protein
BCG_2624 BCG_2624 4.1276 0.009472594 Probable conserved integral membrane protein. 59 aa long.
BCG_0112 BCG_0112 4.0751 3.50E−24 Hypothetical protein. Orthologous to Rv0079, part of the DosR-regulon. Contains a 46 aa region (out of 273 aa) with Sigma 54 modulation/S30EA ribosomal protein C-terminus (2.2e−11)
BCG_2082 BCG_2082 3.5644 0.006797916 Conserved hypothetical protein
BCG_2051 BCG_2051 3.4061 4.19E−17 Conserved hypothetical protein Acg. Part of the DosR-regulon.
BCG_2653c BCG_2653c 3.3755 2.16E−12 Conserved hypothetical protein. Orthologous to Rv2626c, part of the DosR-regulon. Contains CBS pair domain found in Hypoxic Response Protein 1 (HRP1) -like proteins (4.13e−50).
BCG_3157c BCG_3157c 3.357 8.15E−16 Conserved hypothetical protein. Orthologous to Rv3134c, in operon with dosR, part of the DosR-regulon. Universal stress protein family.
BCG_1628 BCG_1628 3.324 9.27E−06 Conserved hypothetical protein
BCG_1777 BCG_1777 3.2859 6.02E−21 Conserved hypothetical protein. Orthologous to Rv1738, part of the DosR-regulon
BCG_1772c BCG_1772c 3.1827 1.13E−12 Probable conserved transmembrane protein. Orthologous to Rv1733c, part of the DosR-regulon.
PE_PGRS42d BCG_2505c 3.1391 0.000695518 PE-PGRS family protein [second part]
TB31.7 BCG_2650 3.1235 2.72E−10 Conserved hypothetical protein TB31.7. Orthologous to Rv2623, part of DosR-regulon. Universal stress protein family.
BCG_0115 BCG_0115 3.1231 1.05E−05 Probable oxidoreductase. Orthologous to Rv0082.
BCG_3454c BCG_3454c 3.0372 0.000216715 Conserved hypothetical protein. Type II toxin-antitoxin (TA) system Phd/YefM family antitoxin similar to Mycobacterium tuberculosis VapB antitoxins
BCG_1838c BCG_1838c 3.0323 1.20E−09 Hypothetical protein
BCG_2178c BCG_2178c 3.032 0.008749493 Conserved hypothetical protein. Contains Flavin-utilizing monoxygenases (4.46e−58)
BCG_0614 BCG_0614 3.0014 4.54E−15 Conserved hypothetical protein. Orthologous to Rv0569, part of the DosR-regulon.
hspX BCG_2050c 2.8196 1.61E−09 Heat shock protein hspX. Orthologous to Rv2031c, alpha crystalin, part of the DosR-regulon.
thiE BCG_0453c 2.8106 0.000357906 Probable thiamine-phosphate pyrophosphorylase thiE
BCG_0113 BCG_0113 2.7983 1.12E−06 Conserved hypothetical protein. Orthologous to Rv0080. Part of the DosR-regulon. Contains a Pyridoxine 5’-phosphate (PNP) oxidase-like and flavin reductase-like proteins domain (1.66e−19)
PE_PGRS13 BCG_0885 2.7947 3.02E−14 PE-PGRS family protein
BCG_0114 BCG_0114 2.7491 0.000116177 Probable transcriptional regulatory protein. Orthologous to Rv0081. Part of the DosR-regulon.
BCG_0168 BCG_0168 2.6959 3.97E−05 Pseudogene
BCG_2563 BCG_2563 2.6227 0.009558631 Hypothetical alanine rich protein
BCG_3001 BCG_3001 2.6148 0.009815904 Possible conserved secreted protein
BCG_3287c BCG_3287c 2.6089 4.29E−05 Conserved hypothetical protein
BCG_0662 BCG_0662 2.592 1.93E−08 Probable integral membrane protein
BCG_3154 BCG_3154 2.5861 1.09E−07 Conserved hypothetical protein. Orthologous to Rv3131, part of the DosR-regulon.
BCG_2049c BCG_2049c 2.5844 9.49E−08
Conserved hypothetical protein. Orthologous to Rv2030c, part of the DosR-regulon. Contains N-terminal (aa 
15-228) Phosphoribosyl transferase (PRT)-type I domain (4.14e−98) and another stretch (aa 223-663 out of 
681) with Erythromycin esterase homolog domain (8e−155)
leuT leuT 2.5789 0.005156523 tRNA-Leu
BCG_3716c BCG_3716c 2.5574 0.00164617 Probable conserved transmembrane protein. Contains Flp pilus assembly protein TadB domain (3.29e−41)
BCG_0010c BCG_0010c -4.5012 4.50E−31 Probable conserved membrane protein. It contains a 40 aa stretch (out of 111 aa) similar to bacterial plekstrin homology domain (2.65e−8)
BCG_0040c BCG_0040c -4.435 4.43E−17 Probable conserved membrane protein. It contains a 40 aa stretch (out of 111 aa) similar to bacterial plekstrin homology domain (2.65e−8)
BCG_3494c BCG_3494c -4.2797 3.95E−16 Hypothetical protein
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on the same set of transcription results. For RankProduct, RoundRobin, and SAM, we used RPKM abundance 
units and for DESeq2 and EdgeR, raw read count abundance units were used. Next, we combined gene DE rank 
positions across all 5 DE tools. This consists of averaging a gene’s rank position in all 5 results, using a generalized 
mean to the 1/2 power, to yield the gene’s final net rank position. Similarly, explicit measurements of differential 
expression (fold change -FC-) and significance (p value) determined by each DE tool were combined via appro-
priate averaging (arithmetic and geometric mean, respectively). Genes with averaged absolute  Log2 FC bigger 
than one and multiple hypothesis adjusted p value below 0.05 were considered differentially expressed. When 
gene function was predicted for those Conserved Hypothetical Proteins (CHP) and Hypothetical Proteins (HP) 
found among the 30 most up- or down-regulated genes during biofilm formation, we took the whole predicted 
protein sequence from BCG Pasteur 1173P2 (https ://www.genom e.jp/kegg-bin/show_organ ism?org=mbb), and 
used to search for Conserved Domains using the CD-Search tool from NCBI (https ://www.ncbi.nlm.nih.gov/
Struc ture/cdd/wrpsb .cgi).
Reverse transcription coupled to quantitative pcR (Rt‑qpcR). In order to independently deter-
mine the relative expression of genes selected from RNA-Seq experiments, total RNA samples obtained from 
additional cultures grown as biofilms (days 1, 7, 10, and 14) or planktonic cells (OD600nm 0.3 and ≈ 1.7) were 
quantified by UV spectroscopy and shipped to Centro Médico Siglo XXI for real time qPCR assays.This was 
conducted essentially as  described9. Briefly, cDNA was synthesized using 500 ng of RNA, 0.2 µg/µl of random 
hexamer primers and 2 U/µl of Revertaid M-MulV-RT (Thermo Scientific). Specific gene primers are listed in 
Table 1. Control reactions were run in all experiments, with no transcript detected. Quantitative real-time PCR 
was performed in a LightCycler 480 instrument (Roche) and 16S rRNA (rrs) was used as a reference gene for 
normalization. The relative gene expression was calculated using the  2−ΔΔCt method48.
Construction of recombinant plasmids to drive expression of selected genes under the strong 
promoter hsp60. Primers used to amplify the open reading frame (ORF) of each one of the selected genes, 
recombinant plasmids generated, bacterial strains used in this work, and primers used for real time qPCR are 
indicated in Table 1. ORFs were amplified from genomic DNA obtained from BCG Pasteur by PCR using high 
fidelity Q5 DNA polymerase (New England Biolabs), digested with specific endonucleases and cloned under the 
Gene_Name Gene_ID Log2fold Avg_p value Product
BCG_2159c BCG_2159c -3.4146 1.35E−24 Hypothetical protein
BCG_2673c BCG_2673c -3.3701 2.34E−07 Hypothetical protein
BCG_3307c BCG_3307c -3.312 1.66E−11 Probable conserved transmembrane protein. It contains a 75 aa stretch (out of 111 aa) similar to bacterial plekstrin homology domain (4.36e−18)
BCG_0088 BCG_0088 -3.2898 6.03E−20 Hypothetical protein
rho BCG_1357 -3.2069 1.45E−12 Probable transcription termination factor rho homolog
BCG_1104c BCG_1104c -3.1715 3.72E−28 Hypothetical protein
rpsM BCG_3525c -3.1288 2.36E−19 Probable 30S ribosomal protein S13 rpsM
BCG_3139 BCG_3139 -3.09 7.74E−06 Conserved hypothetical protein. tRNA(Arg) A34 adenosine deaminase TadA domain (1.47e−34)
BCG_1926c BCG_1926c -3.0538 0.000420994 Conserved hypothetical protein. S-adenosylmethionine-dependent methyltransferases domain (6.49e−22)
BCG_1350 BCG_1350 -3.0417 2.98E−05 Hypothetical protein
BCG_1001c BCG_1001c -3.039 0.000254116 Probable mycolyl transferase. 76 aa, similar to FbpC.
BCG_2748c BCG_2748c -3.0182 6.70E−24 Conserved hypothetical protein. Contains a three-Cys-motif partner protein domain (8.96e−66)
BCG_1115 BCG_1115 -2.9826 5.71E−10 Conserved hypothetical protein. Contains a DNA-binding beta-propeller fold protein YncE (1.79e−34)
dnaA_2 BCG_0031 -2.9643 3.00E−24 Chromosomal replication initiator protein dnaA
PPE70 BCG_3183c -2.9502 6.02E−20 PPE family protein
BCG_3911 BCG_3911 -2.9473 1.83E−08 Probable conserved transmembrane protein. Putative Ca2+/H+ antiporter (2.81e−61)
BCG_3929 BCG_3929 -2.9222 4.01E−22
Conserved hypothetical protein. Orthologous Rv3866 (EspG). A deletion of espG in M. marinum reduced 
sliding motility and biofilm formation by M. marinum (Front Microbiol. 2018 May 30;9:1160. https ://doi.
org/10.3389/fmicb .2018.01160 ).
BCG_2192c BCG_2192c -2.9092 9.86E−14 Possible transposase
lpqK BCG_0436c -2.9037 3.46E−08 Possible conserved lipoprotein lpqK
rpsK BCG_3524c -2.8992 1.14E−17 Probable 30S ribosomal protein S11 rpsK
dnaA_1 BCG_0001 -2.8632 5.63E−22 chromosomal replication initiation protein dnaA
BCG_1987c BCG_1987c -2.8213 1.10E−10 Hypothetical protein
BCG_0078c BCG_0078c -2.8174 1.00E−14 Conserved hypothetical protein. N-terminal (74 aa) with Transcriptional regulator PadR-like family domain (3.67e−22)
rpoA BCG_3522c -2.7989 2.70E−08 Probable DNA-directed RNA polymerase (alpha chain) rpoA
BCG_3899 BCG_3899 -2.7944 8.14E−08 Conserved hypothetical protein. Contains Minimal MMP-like domain (6.69e−50)
lprR BCG_2566 -2.7685 1.32E−05 Probable conserved lipoprotein lprR. Orhtologous to lppA
Table 2.  The thirty genes showing the highest differential expression (up- or down-regulated) at the 
intercellular aggregation step during biofilm production by BCG.
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hsp60 promoter in  pMV36117. Identity and fidelity of the ORFs was confirmed by DNA sequencing. Amplify4 
for MacOS was used to design and test primers. DNA Strider 3.0 for MacOS was used for virtual cloning and 
plasmid characterizations. Sequence fidelity of cloned ORFs was evaluated using BLAST alignments both locally 
with DNA Strider 3.0 for MacOS and by direct comparison with genome sequences of BCG Pasteur 1173P2 
(https ://www.genom e.jp/kegg-bin/show_organ ism?org=mbb). Recombinant plasmids were transformed into 
BCG by electroporation and selected on Middlebrook 7H10 (BD) OADC (BD-BBL) with 0.5% glycerol (Sigma) 
agar plates containing 25 µg/mL of kanamycin (Sigma).
Growth curve and bacterial enumeration. Planktonic cultures were performed in Middlebrook 7H9 
liquid media (BD) with 10% OADC, 0.2% glycerol, 25 µg/mL of kanamycin, at 37 ºC, 100 rpm, with a starting 
OD600nm of 0.03, to read OD600nm every 24 h. When each strain reached OD600nm of ≈ 0.3 (early-log), ≈ 0.6 
(mid-log) and ≈ 1.7 (stationary phase), we took 1 mL samples. Serial dilutions of these samples were followed by 
plating 50 µL aliquots onto Middlebrook 7H10 agar plates supplemented with 10% OADC, 0.5% glycerol, and 
25 µg/mL kanamycin served to determine colony-forming units per milliliter (CFU/mL).
Ziehl–Neelsen staining. We used 10 µL aliquots from mid-log phase samples (planktonic cultures) or a 
loop of fully mature biofilms (2 weeks-old) taken with a disposable inoculating loop (BD 220,215). After fixation, 
staining was performed with a Ziehl–Neelsen kit (Hycel, https ://www.hycel .com.mx/produ ctos/kit-color antes /) 
according to the manufacturer´s instructions.
Quantification of biofilm by crystal violet staining. All mycobacterial strains were cultured in Sauton 
media, started at OD600nm 0.03, in 24-well (M. tuberculosis) or 48-well non-treated tissue culture plates (BCG 
strains), and were incubated at 37 °C, 5%  CO2. Each strain was inoculated into 6 different wells, and experi-
ments were repeated three times for statistical analysis. After 10 days (BCG strains) and 14 days (BCG strains 
and M. tuberculosis strains) of incubation, liquid media was removed and the whole surface pellicle and biofilm 
attached to the wells (these samples are referred to as “biofilms”) was maintained. Plates were baked at 30 °C for 
24 h and 1 ml of 100% methanol was added to each well and incubated at room temperature for 15 min. Then, 
methanol was removed, and plates were dried at 37 °C for 15 min. Crystal violet (CV) was added to each well and 
incubated at 37 °C for 5 min. CV was removed and each well was washed four times with deionized water. Plates 
were dried at 37 °C for 15 min. Dye was extracted with 30% acetic acid for 15 min at 37 °C. Then the extract 
from each well was diluted 1:10 (M. tuberculosis), 1:20 (BCG, 10 days cultures), or 1:40 (BCG, 14 days cultures) 
in 30% acetic acid and read for OD550nm.
Statistics. Data distribution for qPCR, CFU, and biofilm quantification were analyzed using the Anderson–Dar-
ling and Shapiro–Wilk tests, and found to follow a normal distribution in all instances. Growth (as OD600nm 
readings) of rBCG strains was compared with that of parental BCG harboring the empty vector pMV361 (BCG 
WT::pMV361) using Two-Way ANOVA followed by Dunnett’s multiple comparison test. Growth (as doubling 
time) was compared by One-Way ANOVA (logarithmic phase cultures) or Brown–Forsythe and Welch ANOVA 
(stationary phase cultures) followed by Dunnett’s multiple comparison tests. Bacterial replication (CFU/mL) 
was compared by 2-Way ANOVA followed by Tukey’s multiple comparison test. For quantification of biofilms, 
statistical significance was determined using One Way ANOVA followed by Dunnett’s test for multiple compari-
son. For RT-qPCR analyses, Brown-Forsythe and Welch ANOVA followed by Dunnett’s multiple comparison 
test was used for comparing biofilm samples; multiple t tests followed by Holm–Sidak multiple comparison test 
was used for comparing planktonic samples. GraphPad Prism 8 for MacOS was used for performing statistical 
analyses. Assays were conducted in three independent times, and the number of replicates per experiment is 
indicated in each figure legend.
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